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 Hypertension is the leading risk factor for cardiovascular diseases and strokes [1]. A 
portion of these patients exhibit SSHTN with high cardiovascular risk and are more difficult to 
pharmacologically control. The etiology of chronic hypertension includes renal immune cell 
accumulation and sodium retention. The lymphatic system maintains interstitial homeostasis and 
an expansion of lymphatic vessels is necessary to resolve inflammation. We have previously 
demonstrated that specifically increasing renal lymphatic density prevents HTN in mice [2]. 
These mice, KidVD+, undergo kidney specific lymphangiogenesis through the overexpression of 
VEGF-D [3]. The HTN prevention in the KidVD mice is attributed to a common role for 
lymphatics: a reduction in renal immune cell numbers. We have recently identified that these 
mice with expanded renal lymphatics demonstrate increased sodium excretion [2]. The aim of 
this study is to identify the mechanism by which enhancement of renal lymphatics correlates 
with urinary Na+ excretion, and sensitivity to hypertensive stimuli. To improve the diagnostics 
and increase treatment efficacy, the mechanism of lymphatic expansion and Na+ retention within 
the kidney lymphatics may thus prove to be a potential therapeutic target for patients afflicted 




I would like to thank Dr. Joseph Rutkowski his guidance and mentorship over the past 
three years. I would also like to acknowledge the Mitchell Lab for their collaboration, and my lab 
family for all that I have learned in my time at Texas A&M University. 
I would also like to thank my family for their continued support in my academic, 





HTN  Hypertension 
SSHTN Salt-Sensitive Hypertension 
L-NAME nitro-L-Arginine Methyl Ester hydrochloride 
HSD  High Salt Diet 
KidVD Kidney-specific VEGF-D overexpression mice 
BP  Blood Pressure 
VEGF-D Vascular endothelial growth factor 
VEGFR-3 Vascular endothelial growth factor receptor-3 
DLOH  Descending Loop of Henle 
ALOH  Ascending Loop of Henle 
PCT  Proximal Convoluted Tubule 
DCT  Distal Convoluted Tubule 
NHE3  Na+ H+ Exchanger 3 
NKCC  Na+ K+ Cl- Cotransporter 
NCC  Na+ Cl- Symporter 
ENaC  Epithelial Sodium Channel 
IL-17A Cytokine interleukin 17A 
IFN- γ  Cytokine interferon gamma 







Hypertension is a leading cause and contributor to a majority of deaths in the United 
States [1]. Hypertension, otherwise known as chronic high blood pressure, is characterized by an 
increased blood volume traversing through the vasculature or an increased vessel constriction. 
The kidneys’ balance of Na+ excretion and reabsorption in the nephron plays a key role in blood 
volume control. The excretion of Na+ in the urine is referred to as natriuresis and the 
commensurate excretion of water is known as diuresis. An imbalance of renal solute regulation 
can lead to hypertension. Specifically, chronic hypertension can be maintained by the kidney 
only fractionally excreting excess Na+ in urine. Hypertension has also been correlated to high 
salt intake which alters the osmolarity in tissue and blood fluids. An increased molar amount of 
Na+ will require a higher fluid volume in order to maintain constant Na+ concentrations and 
prevent cell lysis [4]. The increase in salt intake can also stimulate physiological changes in 
extrarenal areas such as the liver, dermis, and lymphatic vessels. These changes have been 
hypothesized to be due to changes in tissue Na+ storage, downstream of reabsorption [5].   
The exact etiology of hypertension has numerous factors involved that can be a unique 
combination for each patient[1]. However, some researchers have postulated that renal immune 
cell infiltration and subsequent renal Na+ transporter activation is involved in elevating blood 
pressure [6]. Although there are multiple treatments, some patients are unresponsive to these 
therapies or develop a resistant. In defining the role lymphatic expansion in the prevention of 
hypertension, further research may translate into impactful treatments for at-risk patients.   
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Renal Inflammation and Immunology in Hypertension 
Chronic renal inflammation has also been linked to HTN. Inflammation involves the 
release of numerous cytokines that attract a variety of effector cells and induce extravasation. 
This leads to an increase in local tissue fluid or swelling known as edema. Uncontrolled 
inflammation is capable of decreasing the function of the kidney due to the local pressure 
buildup and other factors. The most popular route for immune cells is the lymphatic network, 
therefore the lymphatic system has been identified to play a role in the hypertensive response [3]. 
This mechanism is considered a positive feedback loop: the release of cytokines in the kidneys 
attracts a local upregulation of angiotensin II production [6, 7]. Angiotensin II antagonizes 
natriuresis by activation of Na+ transporters in the nephrons. In addition, IFN-γ and IL-17A and 
other unidentified cytokines have been shown to play a large role in regulating the Na+ 
transporter activities [6]. Circulating macrophages in lymphatics are also involved in the 
migration of sodium and electrolyte balance [8]. 
Nephron Anatomy & Physiology 
The nephron is the physiological unit of the kidney and balances the blood electrolytes 
during filtration. The kidney is divided into the deep renal medulla and the superficial renal 
cortex, the cortex housing the distal portion of the nephron. Filtration begins when blood from 
the renal artery flows into the nephron at the Bowman’s Capsule in the renal cortex. Here, the 
larger components of blood are filtered out by the Glomerulus. The filtrate subsequently passes 
into the Proximal Convoluted Tubule (PCT) where reabsorption begins. The PCT contains 
Na+/K+/ATPases at the basolateral membrane of the tubular epithelial cells and NHE3, a 
Na+/H+ antiporter at the apical membrane [9]. Approximately 2/3 of sodium reabsorption occurs 
at the PCT [6].  
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The filtrate then flows into the Descending Loop of Henle (DLOH), which initially 
resides in the renal cortex, but curves deeper into the increasingly saltier environment of the 
inner renal medulla. The DLOH is permeable to water but impermeable to ions, thus allowing for 
the high concentration of Na+ in the medulla to drive water diffusion into the interstitial space. 
The high salt gradient of the medulla is maintained by the vasa recta, the group of capillaries that 
transports reabsorbed fluid back into circulation.[10] As filtrate travels further in the nephron, it 
reaches a thicker part of the tubule known as the Ascending Loop of Henle (ALOH). The ALOH 
has numerous Na+ transporters, including NKCC-1 and NKCC-2, that reabsorbs Na+ and other 
ions from the filtrate. The ALOH relies on both passive and active transport of Na+, and is 
responsible for approximately 25% of the total Na+ reabsorption [9].  
The filtrate then passes into distal convoluted tubule (DCT) which contains NCC an 
important sodium chloride co-transporter. The DCT plays a role in the balance of K+, Na+, Ca2+ 
and blood pH. This portion of the nephron is key in the finer control of blood pressure and 
volume regulation as 8% of the NaCl is reabsorbed here [9]. The filtrate then flows into the 
collecting duct where the ENaC family of proteins reabsorbs additional Na+ and water prior to 
release of the filtrate into the renal pelvis, with subsequent urine excretion.  
Renal Na+ Transporters 
Our studies investigated the functions of the distal and proximal nephron transporter 
proteins: NKCC-1, NKCC-2, NCC, NHE3, as well as ENaC. NKCC-1 and NKCC-2 are located 
in the ALOH. Upon activation, NKCC-1 and NKCC-2 function as basolateral and apical 
symporters, respectively. They transport Na+, K+, and Cl- from the filtrate into the epithelial 
cells of the ALOH and ultimately back into circulation. NKCC-1 resides mainly in the thin 
ALOH and NKCC-2 is found in the thick ALOH [9].  
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The DCT contains NCC, which is also known as the Thiazide-sensitive Na+ Cl- 
cotransporter. NCC reabsorbs Na+ from the glomerular filtrate through the apical membrane of 
the tubular epithelial cells. Both the NKCC transporters and NCC are activated upon 
phosphorylation.  
ENaC is also known as the Amiloride-sensitive Na+ channel and is located in the 
collecting ducts. This protein is activated upon cleavage into ENaC- γ, ENaC- α, and ENaC- β. 
Previous studies have shown a correlation of increased activity of these transporters and thus an 
increase in renal filtration rate in mice with a HSD [6]. All of the transporters can be regulated 
using transcriptional and post-transcriptional regulation as well, and these mechanisms need to 
be fully characterized. 
Lymphatic Physiology  
The lymphatic system has recently been considered to play a role in regulation of blood 
pressure [11]. The overall functions of the lymphatic system are in providing a route for immune 
cell, lipid, protein, and interstitial fluid flow. Namely, the lymphatics provide a conduit for 
clearance of interstitial fluid and passage to the lymph nodes [12]. This allows for antigens to be 
presented to the cells of the adaptive immunity to optimally attack any invaders in the case of 
infection. The lymphatic system can also deliver new immune cells to sites of injury and can 
clear them from the inflamed area, and in this way can either perpetuate or attenuate 
inflammation. The capacity that the lymphatics carryout is tissue-specific and is also dependent 
on the timing of lymphangiogenesis [12]. Lymphangiogenesis is defined as the growth of new 
lymphatic vessels, this growth can be stimulated by both VEGF-C and VEGF-D with the latter 
being more of an initial instigator of vessel growth. In some chronic inflammatory diseases, 
lymphangiogenesis does worsen the disease by allowing for an increased infiltration of immune 
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cells and fluid, this is known as IAL (Inflammation-Associated Lymphangiogenesis). Recent 
studies have also identified a role of the trafficking immune cells in secreting VEGF-C in states 
of inflammation, leading to further IAL [13]. Other studies have also demonstrated the role of 
dermal lymphatics in the regulation of excess Na+ storage in the skin upon a chronic HSD or 
SSHTN models. They have shown that increased Na+ content in the skin is correlated with 
increased blood pressure [14].  
Renal Lymphatics 
Studies have indicated little presence of a lymphatic network in the renal medulla, 
however it has been proven that there are lymphatics present in the renal cortex [15]. The renal 
medulla contains segments of the DLOH, ALOH, and collecting ducts whereas the renal cortex 
contains the entire lengths of the PCT, DCT, and bowman’s capsule. The differences in function 
of each segment, as previously discussed, creates differences between the medullary and cortical 
interstitial fluid, the medulla being more concentrated. This then poses the question of why there 
is an apparent lack of lymphatics in the medulla, and what the direct role of renal lymphatics is 
in kidney function. Several researchers have discovered the link between interstitial albumin 
protein clearance by the lymphatics and the differential concentrations of albumin in the medulla 
and cortex that contribute to the proper oncotic gradients needed for their respective functions 
[15]. Although the renal medulla rarely contains lymphatic capillaries, it does utilize the vasa 
recta to transport interstitial fluid [10, 15, 16].  
Numerous studies have indicated the correlation between renal lymphatic dysfunction 
and renal interstitial edema [15, 17, 18]. Without proper functioning of the renal lymphatics there 
is a decreased ability of the kidney to clear out the accumulating interstitial fluid which 
exacerbates the edema. Similarly, in the case of congestive heart failure, the excess pressure load 
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on the renal lymphatics leads to lymphatic dysfunction [15, 19, 20]. Researchers have shown that 
this perpetuates renal edema and increased Na+ retention. Litigation of the renal lymphatics 
results in renal inflammation and fibrosis [21], and interestingly, an elevation in blood pressure 
[22]. Overall, the proper functioning of the renal lymphatic network is likely to be key to 
maintaining a normally functioning kidney and the homeostatic balance of Na+ reabsorption and 
natriuresis.  
Lymphatic Expansion 
Lymphatic expansion due to lymphangiogenesis includes both increased lymphatic 
branching and lymphatic width. As previously discussed, the lymphatic network plays a role in 
the regulation of electrolyte balance [5]. In addition, lymphatic expansion is linked to migration 
of macrophages into the renal cortex and medulla [2]. Our KidVD (Kidney-specific VEGF-D 
overexpression mice) expression system is activated upon addition of Doxycycline hylate, 
triggering the genetic overexpression of VEGF-D and therefore instigating lymphangiogenesis in 
the renal tissues [2, 3]. These mice have been shown to be resistant to hypertension, in part 
through limiting immune cell accumulation [2]. As hypertension is also a condition of sodium 
retention, these mice provide a clever model to identify if increased renal lymphatic density also 







KidVD+ and wildtype (WT) mice were used for all experiments. All mice were fed on an 
ad libitum diet of their respective chow and water. The Chronic Na+ group was given 4% NaCl 
chow with 1% NaCl water with 200 mg/L of doxycycline hylate (Sigma-Aldrich) for three 
weeks. The baseline cohort was similarly administered 200 mg/L of doxycycline hylate in their 
water.  
The acute Na+ loading group received 200 mg/L of doxycycline in their water for three 
weeks followed by an intraperitoneal injection of isotonic saline solution at 5% body weight. 
These mice then underwent a 10-hour acclimation period, followed by placement in urine 
collection cages where their urine was collected hourly for 6 hours.  
The SSHTN cohort was administered L-NAME in their water ad libitum for 2 weeks, 
followed by a week-long wash-out period with normal water [3]. At week 4, a subsequent week-
long dose of 200mg/L doxycycline was administered. Then at week 5, 1% NaCl was added to the 
doxycycline water. All mice were sacrificed by administration of isofluorane and cervical 
dislocation. Liver tissue, both kidneys, back skin (hair removed with Nair), ears, cardiac tissue, 
skeletal muscle tissue, and blood were collected.  
Urine Analysis 
Urine excretion data collected from the from the acute Na+ loading group was analyzed 
by the UT Southwestern Charles and Jane Pak Center for Mineral Metabolism and Clinical 
Research. Measurements were obtained using the Beckman AU400 Autoanalyzer.  
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Dermal Lymphatic Quantifications 
Ear specimens were pealed in half, separating the anterior and posterior sides, and were 
fixed in 10% buffered formalin solution (Sigma, St. Louis, MO) for approximately 2 hours. They 
were then rinsed in 1x PBS, and the posterior half of the ear was soaked in 0.3% detergent (0.1% 
Tween and 0.2% Triton X). The samples were then incubated in Lyve-1 (polyclonal goat; R&D 
Systems, Minneapolis, MN) at a 1:400 dilution by volume in AquaBloc (EastCoastBio, North 
Berwick, ME) for 3 days at 4℃. After rinsing, the ears were incubated for 3 days in donkey IgG 
anti-goat 488 (Life Technologies, Carlsbad, CA) using the same dilution process as the primary 
antibody. The interior portion of the ear was imaged using a fluorescence stereoscope at 5x 
magnification. Images of ears were taken of the edge to center of ear. Total branches, length, and 
widths were collected for a standardized area using ImageJ software.  
Tissue Sodium Quantifications 
Wet weights of transversely-sliced kidney tissue halves were obtained. Samples were 
boiled for 4 days at 110℃ to remove water content. Dried samples were weighed and 
subsequently oxidized using 500 µL of 12 N HCl at 82℃ for 3 days. The samples were 
resuspended in 500 µL of deionized water and sonicated for 10 minutes. Samples were 
centrifuged for 10 minutes at 11g, then 100 µl of each sample was analyzed using the Horiba 
Scientific, LAQUAtwin, compact water quality meter, sodium sensor. Calculations were 
performed to normalize each sample’s original weight to the concentration output. Skin sodium 
quantifications were performed in a similar manner. Skin processing, however, differed by the 
incubation times: the back-skin samples (30-200 mg) were boiled for 12 days and oxidized for 5 
days under temperature conditions previously mentioned (see Appendix A for further detail).  
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Tissue Collagen Quantification 
 Weight of collagen in the dehydrated and oxidized kidney and skin samples was obtained 
using the hydroxyproline assay (see Appendix A). 100 µL of sample was combined with 250 µL 
of 1.4% Chloramine-T in 0.5 M sodium acetate/10% isopropanol. Mixture incubated for 20 
minutes at room temperature, and then 250 µL of Ehrlich’s solution (1M p-
dimethylaminobenzaldehyde in 70% isopropanol/30% perchloric acid) was added and incubated 
for 15 minutes at 65℃. Concentrations were measured using a spectrophotometer at 550 nm.  
Protein Extraction and Immunoprecipitation  
Transverse halves of renal tissue homogenate was purified and protein lysates were 
extracted, following the BCA assay, to obtain the protein concentrations. Volume for 
immunoprecipitation was kept constant at 30 µL for each sample, and protein concentrations 
were approximately 1.2mg/mL. Antibodies used were for NKCC-1, NKCC-2, NCC, ENaC- α 
sodium transporters (see Appendix B). Each primary antibody was rabbit derived and used at a 
1:1000 dilution in Odyssey Blocking Buffer (LI-COR, Lincoln, NE). The secondary antibodies 
were used at a 1:5000 dilution similarly. The blots were then re-probed in a similar manner using 
the phospho-tyrosine antibody afterwards on same blot to determine activation of each protein. 
Statistical Methods 
The Student’s T-test was utilized to determine significant relationships between 2 







Increased Fractional Excretion in KidVD+ Mice 
There was a statistically significant increase in the excretion of Na+ across the KidVD+ 
chronic Na+ loading cohort as compared to the KidVD- for both males and females as 
demonstrated in Figure 1. In addition, there was a statically significant increase in fractional 
excretion in the chronic Na+ loading mice as compared to the chow fed mice (see Figure 1). 
 
 
Figure 1. Fractional Na+ Excretion in urine. The Combined male and female fractional 
excretion data collected from the chow mice and the acute Na+ loading mice on a percent added 
to diet basis. *P < 0.05. 
 
Absence of Na+ Accumulation in Skin and Kidney Tissues 
There was no statistically significant difference in skin or kidney tissue Na+ 
concentrations between the Chow fed KidVD- and KidVD+ mice as shown in Figures 2A and 

































compared to the KidVD+ acute Na+ Loading cohort as seen in Figure 2A. The KidVD+ SSHTN 
mice had an elevated level of Na+ in the kidney tissues, however, the Chronic Na+ mice showed 
no change in kidney Na+ between the two genotypes, demonstrated in Figure 2A. The skin 
samples had a relatively constant Na+ concentration across all cohorts and genotypes ranging 
from approximately 0.1 mM to 0.16 mM (see Figure 2B). 
 
 
Figure 2. Tissue Sodium concentrations. Concentrations of tissue sodium content was 
analyzed for kidney and skin tissues and was normalized to sample weight. A. Kidney fluid 
sodium concentration. B. Skin fluid sodium concentration. *P < 0.05. 
 
Absence of Dermal Lymphangiogenesis in KidVD+ Mice 
There was a statistically significant decrease in dermal lymphatic density in the SSHTN 
KidVD+ mice as compared to the SSHTN KidVD- mice as demonstrated by both Figures 3A 
and 3B. There was a statistically significant increase in the total lymphatic vessel length per area 
for both KidVD+ and KidVD- mice in the SSHTN cohort as compared to their chow fed 
counterparts (see Figure 3A). There was also a statistically significant increase in the number of 
branchpoints per area in the SSHTN KidVD+ and KidVD- mice as compared to the chow fed 
mice (see Figure 3B). The SSHTN KidVD+ mice showed a lesser amount of vessel density 
B A 
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increase as compared to the SSHTN KidVD- mice in both the total number of branchpoints and 
total vessel length per area shown in Figure 3A and 3B. 
 
 
Figure 3. Dermal lymphatic vessel quantification. A. Displays the average vessel Length 
per unit area analyzed in both the chow fed mice (LHTN) and SSHTN mice. B. Displays the 
average number of branchpoints per unit area analyzed in both chow fed mice (LHTN) and 
SSHTN mice. Both sets of data are from the previous study conducted by the Rutkowski lab [2, 
3]. *P < 0.05. 
 
Tissue Collagen Levels Unchanged 
There was no significant changes in the relative amounts of collage in the kidney and 
skin tissues of the mice across all cohorts demonstrated in Figures 4A and 4B. Significant 




      
Figure 4. Tissue collagen analysis. A. Relative amount of total kidney collagen.  B. 
Relative amount of total skin tissue collagen. Both samples were normalized to dry weights of 
the original tissue sample. *P < 0.05. 
 
Elevated Expression Levels of Na+ Transporters in KidVD- Mice 
There was an overall downregulation in gene expression of renal Na+ transporters in the 
KidVD+ mice as compared to KidVD- mice all on the chronic Na+ diet as seen in Figure 5A. 
There was a statistically significant decrease in genetic expression of NKCC-2, NCC, NHE3, and 
ENaC- γ. In addition, there was a decrease in NKCC-1, ENaC-α and ENaC-β in the KidVD+ 
mice. This result was synonymous with the protein expression of NCC as seen in Figure 5B. The 
expression of NCC in the chronic Na+ loading KidVD+ mice was statistically significantly lower 




    
Figure 5. Renal Na+ transporter expression analysis. A. Genetic expression of renal Na+ 
transporters in KidVD- and KidVD+ acute Na+ loading mice quantitated by RT-qPCR. B. 

































































Protective Mechanisms in the KidVD Model  
In conclusion, the increase in fractional Na+ excretion in the KidVD+ mice is 
explanatory of the HTN resistant phenotype that has been previously described [2]. This finding 
was parallel with the decreased expression of renal Na+ transporters, with NCC playing a 
significant role in the balance of reabsorption and excretion of Na+ in these mice. For the acute 
Na+ loading KidVD- mice, this mechanism for increased Na+ retention, see Figure 1, was 
confirmed by the increased expression of renal Na+ transporters. Increased Na+ retention is 
osmotically followed by an increase in water retention, leading to an increase in blood fluid 
volume and ultimately results in HTN. The acute Na+ loading KidVD- mice also demonstrated 
an increase in dermal lymphatic density. These results are parallel to the findings from Speed et 
al. which demonstrated that with chronic HSD, there was an increased dermal tissue remodeling 
due to the excess storage of Na+ in dermal tissues [14].  
Our results are indicative of a similar dermal tissue remodeling event linked to changes in 
Na+ handling, and most likely dermal Na+ storage. However, the tissue sodium measurements 
did not demonstrate any significant increase in skin Na+ storage (see Figure 3). Although our 
findings on Na+ storage in dermal tissue were insignificant across all cohorts and genotypes, the 
Titze group has previously shown that rats with HSD have utilized the skin as a Na+ storage 
depot and the skin playing a newly characterized role in electrolyte homeostasis [5]. This group 
has also characterized much of the Na+ handling mechanisms in the periphery, and have also 
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utilized more intensive methods to both visualize and quantify Na+ storage throughout the body 
[5, 23].  
Future Directions  
Enhancing renal lymphatics has proved an interesting preventative route for pre-clinical 
treatment of HTN. It has been suggested that increased renal lymphatics allows for an increased 
ability for clearance of immune cells and interstitial fluid. However, this mechanism is 
controversial, and the efficacy of enhanced lymphatics is dependent on both the timing of 
lymphangiogenesis in relation to hypertensive stimulus and the degree of efficiency of the new 
vessels in clearing fluid [11, 24]. There are also studies that have indicated the importance of a  
renal medulla vasculature with characteristics similar to both blood vessels and lymphatics, 
known as the vasa recta, which provide clearance of interstitial fluid from the renal medulla [10]. 
Like lymphatics, the vasa recta also depend on R3 signaling [10]. Further investigation using the 
KidVD model may provide clarity on the role that the vasa recta play in comparison to the 
cortical lymphatics in providing a protective mechanism against HTN and renal edema.  
 Future studies will allow for the elucidation of the specific mechanisms by which the 
kidney and infiltrating immune cells use in regulating the expression and activity of the renal 
Na+ transporters. These mechanisms have a high potential for becoming a therapeutic target in 
patients who suffer from HTN, by preventing excess Na+ reabsorption and storage. In 
discouraging excess Na+ reabsorption, the fluid volume necessary for osmotic balance will 
decrease, therefore preventing high blood pressure. In addition, further characterization of 
specific cytokines and chemokines involved in renal inflammation, and ultimately HTN, will 
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Appendix A. Antibody Information 
Antibody Company Lot 
NCC Abcam 3030545 
α -ENac Invitrogen TE264898 
NKCC-1 Abcam GK3233837-1 
NKCC-2 Abcam GR128934-7 
P-tyrosine Abcam 2593884 




Appendix B. Hydroxyproline Assay Protocol 
(assume collagen = 12.5% hydroxyproline) 
 
**For collection of tissue Na+ concentrations perform steps 1, 5-7, using 500uL of HCl in step 
5 and 500uL to resuspend in step 7. In the heating steps, higher temperatures may be advisable 
and longer periods of heating, use your own discretion for the size of your tissue. After step 7, 
centrifuge the samples to clear all debris and then use 50-100uL of sample to test for sodium 
using the Horiba Scientific, LAQUAtwin, compact water quality meter, sodium sensor and filter 
paper. Proceed to the subsequent steps, using half of the volume required for all reagents and 
samples. If needed for the skin tissues (higher collagen content, samples may all be oversaturated 
and unable to measure), make the standard a serial dilution starting at 2mg/mL, and then dilute 
all samples and the standards by a factor of 10 prior to analysis with spectrometer. The best 
range is not yet known.  
 
1. Weigh and record tissue mass (100-500mg) 
2. Homogenize* in distilled water 
3. Precipitate with 1/5 water volume 50% trichloroacetic acid on ice for 30 minutes.  
4. Spin and remove liquid. 
5. Resuspend precipitate in 1 mL of 12N (36%) hydrochloric acid. Transfer to tall glass tube. 
6. “Boil” off HCl at 110°C overnight – in the fume hood!!! Samples will blacken. They must be 
dry when finished. Continue heating until dry if necessary. Caps off. 
7. Resuspend – it will not go wholly back into solution – in 1mL distilled water** by sonication. 
Black goop stuck to the walls is lipid; don’t worry about it. 
 
Samples in water are stable at room temperature. Let them sit. 
 
Prepare serial dilutions of trans-4-hydroxy-L-proline (Sigma) in water starting at 0.5mg/mL. 
 
Prepare (must be fresh!) 1.4% solution of chloramine T in 0.5M sodium acetate/10% 
isopropanol. 
 
8. In duplicate Eppendorf tubes, add 200µL of samples and standards to 500 µL prepared 
chloramine T solution. Dispense in a hood. 
9. Incubate 20 minutes at room temperature. 
 
While incubating, prepare Ehrlich’s solution: 1.0 M p-dimethylaminobenzaldehyde in 70% 
isopropanol/30% percholoric acid. 
 
10. Add 500 µL of Ehrlich’s solution to each of the sample and standard tubes. Invert to mix. 
11. Incubate at 65°C (a water bath works well for this) for 15 minutes. Higher concentration 
standards will start to turn pink-purple. 
12. Remove from heat and transfer to 96-well plate. 
13. Measure absorbance at 550nm. Standard curve should be linear. 
14. Collagen concentration = hydroxyproline concentration/0.125 
26 
15. Calculate total collagen mass/total mass. Alternatively, after homogenization, take a small 














Typical values (g collagen/100g tissue): liver 0.26, kidney 0.37, spleen 0.73, tendon 56.5 
 
* For collagen rich and lipid poor tissues, the sample can be placed directly into HCl without 
homogenization. Sufficient HCl should be used to cover the sample. Adipose needs to have the 
lipid removed. 
** For adipose, where matrix is so little of the tissue weight, use more tissue in Step 1 and less 
water in Step 6. 
 
Other note: the solutions you’re using are pretty nasty. Wear a lab coat, goggles, and work in a 
hood. The solutions are also very concentrated – make up only enough chloramine T and 
Ehrlich’s for use (500µL each per sample); discard the unused.  
ADDITIONAL NOTES (A REYNA) 
 
1.  If using tissues from -80C they must first be weight “wet” 
-Measure weight of standard glass test tube 
-Add tissue sample and weigh again 
-Subtract these values to get the “wet” weight 
2.  These then need to be completely dried.  Place at 80C up to overnight if needed (For kidney it 
only took 3 hrs.) 
 
Then continue with regular protocol. 
 
